These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32526693)

  • 1. Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: A comparative study with three matched control groups.
    Saroj R; Ghosh A; Subodh BN; Nehra R; Mahintamani T; Rana DK; Basu D
    Asian J Psychiatr; 2020 Oct; 53():102181. PubMed ID: 32526693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence.
    Ghosh A; Mahintamani T; Rana DK; Basu D; Mattoo SK
    Indian J Psychiatry; 2022; 64(2):199-208. PubMed ID: 35494328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross-Sectional Comparative Study.
    Ghosh A; Basu D; Mattoo SK; Kumar Rana D; Roub F
    Am J Addict; 2020 Mar; 29(2):120-128. PubMed ID: 31951069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Functions After 6-Month Buprenorphine (Naloxone)-Based Opioid Agonist Maintenance Treatment: A Controlled Prospective Study.
    Ghosh A; Shaktan A; Nehra R; Verma A; Rana DK; Ahuja CK; Modi M; Singh P; Basu D
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):141-150. PubMed ID: 38421923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study.
    Ghosh A; Shaktan A; Verma A; Basu D; Rana DK; Nehra R; Ahuja CK; Modi M; Singh P
    J Psychoactive Drugs; 2024 Jan; ():1-13. PubMed ID: 38251910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of psychological symptoms and cognitive functions in patients under maintenance treatment with methadone or buprenorphine, current opioid users and healthy subjects.
    Nikraftar NS; Feyzi YF; Ramzani F; Nikbakht-Zadeh M; Amini M; Arezoomandan M; Shiehmorteza M; Arezoomandan R
    Asian J Psychiatr; 2021 Apr; 58():102603. PubMed ID: 33621923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive Functions in Patients with Comorbid Hepatitis C and Opioid Dependence: A Comparative Study.
    Ghosh A; Mahintamani T; Rana DK; Basu D; Mattoo SK; Premkumar M; Singh GK
    Indian J Psychol Med; 2023 Mar; 45(2):146-154. PubMed ID: 36925501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
    Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
    Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder.
    Oral E; Canpolat S; Yildirim S; Gulec M; Aliyev E; Aydin N
    Brain Res Bull; 2012 Aug; 88(5):454-9. PubMed ID: 22498307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study.
    Singh A; Rao R; Chatterjee B; Mishra AK; Kaloiya G; Ambekar A
    Asian J Psychiatr; 2021 Jul; 61():102697. PubMed ID: 34030027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
    Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
    Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional personality beliefs and executive performance in patients with juvenile myoclonic epilepsy.
    Taura M; Gama AP; Sousa AVM; Noffs MHS; Alonso NB; Yacubian EM; Guilhoto LM
    Epilepsy Behav; 2020 Apr; 105():106958. PubMed ID: 32097884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin use and neuropsychological impairments: comparison of intravenous and inhalational use.
    Ghosh A; Shaktan A; Nehra R; Basu D; Verma A; Rana DK; Modi M; Ahuja CK
    Psychopharmacology (Berl); 2023 Apr; 240(4):909-920. PubMed ID: 36779990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher IQ in juvenile myoclonic epilepsy: Dodging cognitive obstacles and "masking" impairments.
    Rzezak P; Moschetta SP; Mendonça M; Paiva MLMN; Coan AC; Guerreiro C; Valente KDR
    Epilepsy Behav; 2018 Sep; 86():124-130. PubMed ID: 30017836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Effect of Chronic Cigarette Use on Cognitive Function].
    Güleç G; Akarsu Ö; Mutlu Şahin F; Eşsizoğlu A; Köşger F; Sezer E; Sonkurt HO
    Turk Psikiyatri Derg; 2018; 29(3):154-161. PubMed ID: 30260461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.
    Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R
    JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Cognitive Functions in Methadone Maintenance Patients.
    Mazhari S; Keshvari Z; Sabahi A; Mottaghian S
    Addict Health; 2015; 7(3-4):109-16. PubMed ID: 26885347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The executive profile of children with Benign Epilepsy of Childhood with Centrotemporal Spikes and Temporal Lobe Epilepsy.
    Lima EM; Rzezak P; Guimarães CA; Montenegro MA; Guerreiro MM; Valente KD
    Epilepsy Behav; 2017 Jul; 72():173-177. PubMed ID: 28622557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.